De Gheldre Y, Maes N, Rost F, De Ryck R, Clevenbergh P, Vincent J L, Struelens M J
Department of Microbiology, Erasme Hospital, Brussels, Belgium.
J Clin Microbiol. 1997 Jan;35(1):152-60. doi: 10.1128/jcm.35.1.152-160.1997.
Molecular typing was used to investigate an outbreak of infection caused by multidrug-resistant Enterobacter aerogenes (MREA) susceptible only to gentamicin and imipenem in an intensive care unit (ICU). Over a 9-month period, ciprofloxacin-resistant E. aerogenes isolates were isolated from 34 patients, or 4.1% of ICU admissions, compared with a baseline rate of 0.1% in the previous period (P < 0.001). Infection developed in 15 (44%) patients. In vivo emergence of imipenem resistance (MIC, 32 micrograms/ml) of organisms causing deep-seated infection was observed in two (13%) of these patients following prolonged therapy with imipenem and gentamicin. Arbitrarily primed PCR (AP-PCR) analysis with ERIC1R and ERIC2 primers and pulsed-field gel electrophoresis (PFGE) analysis of XbaI macrorestriction patterns concordantly showed that outbreak-associated MREA isolates were clonally related and distinct from epidemiologically unrelated strains. AP-PCR and PFGE showed discrimination indices of 0.88 and 0.98, respectively. Space-time clustering of cases within units suggests that the epidemic-related MREA isolates were transmitted on the hands of the health care personnel. A case-control study and repeated environmental culture surveys failed to identify a common source or procedure associated with transmission. In spite of the early implementation of isolation measures, the incidence of MREA colonization remained stable until all colonized patients were discharged. This study confirms the usefulness of AP-PCR and PFGE analyses for the epidemiological study of E. aerogenes and underscores the difficulty of controlling the spread of multiresistant clones of this organism in the ICU setting. The emergence of imipenem resistance represents a threat because virtually no therapeutic option is available for such strains.
采用分子分型方法对重症监护病房(ICU)中仅对庆大霉素和亚胺培南敏感的多重耐药产气肠杆菌(MREA)引起的感染暴发进行调查。在9个月的时间里,从34例患者中分离出耐环丙沙星的产气肠杆菌菌株,占ICU入院患者的4.1%,而前一时期的基线率为0.1%(P<0.001)。15例(44%)患者发生感染。在其中2例(13%)接受亚胺培南和庆大霉素长期治疗的患者中,观察到引起深部感染的病原体在体内出现了亚胺培南耐药(MIC,32微克/毫升)。用ERIC1R和ERIC2引物进行的任意引物PCR(AP-PCR)分析以及XbaI酶切片段的脉冲场凝胶电泳(PFGE)分析一致表明,与暴发相关的MREA菌株具有克隆相关性,且与流行病学上无关的菌株不同。AP-PCR和PFGE的鉴别指数分别为0.88和0.98。单位内病例的时空聚集表明,与疫情相关的MREA菌株是通过医护人员的手传播的。一项病例对照研究和反复的环境培养调查未能确定与传播相关的共同来源或程序。尽管早期实施了隔离措施,但在所有定植患者出院之前,MREA定植的发生率一直保持稳定。本研究证实了AP-PCR和PFGE分析在产气肠杆菌流行病学研究中的有用性,并强调了在ICU环境中控制该生物体多重耐药克隆传播的困难。亚胺培南耐药的出现构成了威胁,因为实际上对于此类菌株没有可用的治疗选择。